Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9562158 | 0.88 | CA2 (0.40) | ALDH1A1TSHRMEN1KMT2AGAA | |
| SCHEMBL4970073 | 0.87 | ALDH1A1 (0.34) | ALDH1A1TSHRMEN1KMT2AGAA | |
| SCHEMBL1325862 | 0.86 | ZDHHC7 (0.41) | ALDH1A1TSHRMEN1KMT2AGAA | |
| SCHEMBL20348151 | 0.86 | ALDH1A1 (0.38) | ALDH1A1TSHRMEN1KMT2AGAA | |
| SCHEMBL4734757 | 0.86 | HDAC1 (0.35) | ALDH1A1TSHRLMNACHRM1AKR1A1 | |
| SCHEMBL29374123 | 0.85 | ZDHHC7 (0.43) | LMNAMAPTCPB2 | |
| SCHEMBL28288321 | 0.85 | ZDHHC7 (0.43) | LMNAMAPTCPB2 | |
| SCHEMBL17079750 | 0.85 | ZDHHC7 (0.43) | LMNAMAPTCPB2 | |
| SCHEMBL21646318 | 0.85 | ZDHHC7 (0.43) | LMNAMAPTCPB2 | |
| SCHEMBL11273438 | 0.84 | CPB2 (0.41) | ALDH1A1TSHRMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101712645-A | Preparation method for (2R, 4R)-4-substituted-2-piperidine carboxylic acid compound and intermediate thereof | CHONGQING WORLD HAORUI PHARM C | 2010-05-26 | — | — | CN | claimed |
| JP-6116200-A | — | — | None | — | — | JP | disclosed |
| CN-119930467-A | Preparation method of 2-cyano-2-propyl valerate and valproic acid | 湖南省湘中制药有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119462421-A | Recovery method and application of 2-cyano-2-valproic acid hydrate | 湖南大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-119118869-A | Recovery method of 2-cyano-2-valproic acid | 湖南省湘中制药有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20170136058-A1 | CO-NETWORK OF HIGH AND LOW MOLECULAR WEIGHT 3-ARM STAR CYANOACRYLATE-TELECHELIC POLYISOBUTYLENE AND 2-OCTYL CYANOACRYLATE | THE UNIVERSITY OF AKRON (US) | 2017-05-18 | — | — | US | disclosed |
| US-20170028099-A1 | METHOD FOR THE PRODUCTION OF POLY(2-OCTYL CYANOACRYLATE)-POLYISOBUTYLENE CO-NETWORK, AND SUPER INITIATORS THEREFOR | THE UNIVERSITY OF AKRON (US) | 2017-02-02 | — | — | US | disclosed |
| CN-101712645-A | Preparation method for (2R, 4R)-4-substituted-2-piperidine carboxylic acid compound and intermediate thereof | CHONGQING WORLD HAORUI PHARM C | 2010-05-26 | — | — | CN | disclosed |
| EP-0315996-B1 | Optically active compound, process for producing same and liquid crystal composition containing same | CANON KK (JP) | 1995-06-28 | — | — | EP | disclosed |
| JP-H06116200-A | NEW FLUORINATED VALPROIC ACID DERIVATIVE AND ANTIEPILEPTIC AGENT | KUREHA CHEM IND CO LTD | 1994-04-26 | — | — | JP | disclosed |
| US-4999130-A | Optically active compound, process for producing same and liquid crystal composition containing same | CANON KABUSHIKI KAISHA (JP) | 1991-03-12 | — | — | US | disclosed |
| EP-0315996-A2 | Optically active compound, process for producing same and liquid crystal composition containing same | CANON KABUSHIKI KAISHA (JP) | 1989-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170136058-A1 | CO-NETWORK OF HIGH AND LOW MOLECULAR WEIGHT 3-ARM STAR CYANOACRYLATE-TELECHELIC POLYISOBUTYLENE AND 2-OCTYL CYANOACRYLATE | TNNC1, PCNA, TAC3 | ALDH1A1 3897/4885TSHR 3824/4885MEN1 4128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.